Literature DB >> 8561778

Inhibition of the H+/peptide cotransporter in the human intestinal cell line Caco-2 by cyclic AMP.

U Muller1, M Brandsch, P D Prasad, Y J Fei, V Ganapathy, F H Leibach.   

Abstract

Treatment of Caco-2 cells with cholera toxin inhibits the activity of the H+/peptide cotransporter. The effect of cholera toxin is mimicked by E. coli heat-labile enterotoxin, forskolin and isobutylmethylxanthine and is associated with an increase in cAMP levels in the cells. The inhibition is due to a decrease in the maximal velocity of the transport system. Inhibitors of protein kinase A and protein kinase C block the effect of cholera toxin. Interestingly, the H+/peptide cotransporter in Caco-2 cells does not possess any putative site for phosphorylation by protein kinase A but does possess sites for phosphorylation by protein kinase C. It appears that the cAMP-dependent inhibition of the H+/peptide cotransporter in Caco-2 cells is mediated through activation of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8561778     DOI: 10.1006/bbrc.1996.0082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 2.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Infectious diarrhea: Cellular and molecular mechanisms.

Authors:  Kim Hodges; Ravinder Gill
Journal:  Gut Microbes       Date:  2010-01

4.  Substrate upregulation of the human small intestinal peptide transporter, hPepT1.

Authors:  D Walker; D T Thwaites; N L Simmons; H J Gilbert; B H Hirst
Journal:  J Physiol       Date:  1998-03-15       Impact factor: 5.182

5.  Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).

Authors:  Catriona M H Anderson; Maria E Mendoza; David J Kennedy; Demetrio Raldua; David T Thwaites
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

6.  Ethanol inhibits functional activity of the human intestinal dipeptide transporter hPepT1 expressed in Xenopus oocytes.

Authors:  Kaixun Li; Liya Xu; Ashutosh A Kulkarni; Daya I Perkins; Ian S Haworth; Daryl L Davies
Journal:  Alcohol Clin Exp Res       Date:  2008-03-11       Impact factor: 3.455

7.  PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.

Authors:  M Buyse; F Berlioz; S Guilmeau; A Tsocas; T Voisin; G Péranzi; D Merlin; M Laburthe; M J Lewin; C Rozé; A Bado
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.